Myeloid-avid mTOR-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantation.
Mineura K, Liu CR, Amrute JM, Kawana S, Elmenshawy FH, Perez JL, Lounsbery-Scaife W, Poddar N, Nunna V, Li W, Terada Y, Meadows A, Heo GS, Wang W, Davighi MG, Morla-Folch J, Park S, Laghlali G, Burgess E, Schotsaert M, Liu Y, Lavine KJ, Ritter JH, Lama VN, Brody SL, Nava RG, Gelman AE, Krupnick AS, Perez-Rodriguez L, Hasson D, Teunissen AJP, Ochando J, Kreisel D.
Mineura K, et al. Among authors: li w.
Am J Transplant. 2026 Jun 6:S1600-6135(26)02582-7. doi: 10.1016/j.ajt.2026.05.2303. Online ahead of print.
Am J Transplant. 2026.
PMID: 42252026
Free article.